Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

(2015) Daniel I Swerdlow et al.   LANCET

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

8. Cardiovascular Disease and Risk Management

(2014)   DIABETES CARE

Validity of diabetes self-reports in the Women’s Health Initiative

(2014) Jody M. Jackson et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus

(2013) Eliano Pio Navarese et al.   AMERICAN JOURNAL OF CARDIOLOGY

All-Cause, Cardiovascular, and Cancer Mortality Rates in Postmenopausal White, Black, Hispanic, and Asian Women With and Without Diabetes in the United States: The Women's Health Initiative, 1993-2009

(2013) Y. Ma et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Racial/ethnic disparities in association between dietary quality and incident diabetes in postmenopausal women in the United States: the Women's Health Initiative 1993–2005

(2013) Yongxia Qiao et al.   ETHNICITY & HEALTH

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Meta-Analysis of Statin Effects in Women Versus Men

(2012) William J. Kostis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

(2012) Paul M Ridker et al.   LANCET

Diet quality and the risk of cardiovascular disease: the Women’s Health Initiative (WHI)

(2011) Rashad J Belin et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

(2011) David Preiss   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin

(2011) David D. Waters et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia

(2010) Samia Mora et al.   CIRCULATION

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US*

(2010) Earl S. FORD et al.   Journal of Diabetes

American Diabetes Association Indications for Statins in Diabetes: Is there evidence?

(2009) R. Eldor et al.   DIABETES CARE

Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements

(2008) Karen L Margolis et al.   Clinical Trials